The Use of CytoSorb Therapy in Critically Ill COVID-19 Patients: Review of the Rationale and Current Clinical Experiences

<div>Potential indications for hemoadsorption in COVID-19 patients. ARDS, acute respiratory distress syndrome; ECMO/ECLS, extracorporeal membrane oxygenation/extracorporeal life support; CRRT, continuous renal replacement therapy; HLH, hemophagocytic lymphohistiocytosis.</div>

Critical Care Research and Practice

fig1

Figure 1

Figure 1: The Use of CytoSorb Therapy in Critically Ill COVID-19 Patients: Review of the Rationale and Current Clinical Experiences 